Skip to main content
Fig. 2 | Journal for ImmunoTherapy of Cancer

Fig. 2

From: Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy

Fig. 2

Six days after the second Listeria-based immunotherapy treatment, mice were euthanized and tumors harvested and profiled for a. total number of CD4+ T cells per 1e6 tumor cells; b. total number of Tregs (CD4+FoxP3+) per 1e6 tumor cells; c total number of non-Tregs (CD4+FoxP3) per 1e6 tumor cells; and d. Percentage of Tregs within the CD4+ T cell population. (*P ≤ 0.05, ** P ≤ 0.01, ***P ≤ 0.001). Experiment was repeated twice with n = 5/group with similar results

Back to article page